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**Background**

Coronavirus infection has been identified in foals and adult horses with pyrogenic and enteric disease; however its significance as a pathogen remains undefined. Recently, Equine Coronavirus (ECoV) has been identified in feces of healthy horses suggesting that inapparent carriers may shed the virus.

**Objective**

The objective of this current, ongoing study was to investigate the presence of ECoV in feces of horses hospitalized for enteric disease (n = 70) or orthopedic conditions (n = 70).

**Methods**

Fecal samples were collected at admission and 48‐72 h thereafter. Presence of ECoV was evaluated using electron microscopy (EM) and RT‐PCR. Categorical analyses will be performed using Kruskal‐Wallis test to determine the association between observations (age, breed, sex, clinical signs, clinicopathological data, EM and RT‐PCR results).

**Results**

Our preliminary data showed that 17% (3/18) of horses with enteric disease were positive for ECoV. These horses had fever (2/3), elevated liver values (1/3), hepatic lipidosis (1/3), and sand enteropathy (1/3). So far, ECoV has not been detected in the orthopedic group (n = 16). Interestingly, a discrepancy between EM and RT‐PCR results was noted and is currently been further investigated.

**Conclusions**

The results of our ongoing study shows that, for our study population, ECoV is detected in a small percentage of horses admitted for enteric disease and is not a common finding in horses admitted for orthopedic conditions. Also, the disagreement between tests for ECoV highlights the need for further research. The data from this study will contribute to our understanding of the role of ECoV in the horse.
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